Anti-biofilm Agents against Pseudomonas aeruginosa : A Structure–Activity Relationship Study of C -Glycosidic LecB Inhibitors

Roman Sommer,Katharina Rox,Stefanie Wagner,Dirk Hauck,Sarah S. Henrikus,Shelby Newsad,Tatjana Arnold,Thomas Ryckmans,Mark Brönstrup,Anne Imberty,Annabelle Varrot,Rolf W. Hartmann,Alexander Titz,Mark Brönstrup

DOI: https://doi.org/10.1021/acs.jmedchem.9b01120

IF: 8.039

2019-09-25

Journal of Medicinal Chemistry

Abstract:Biofilm formation is a key mechanism of antimicrobial resistance. We have recently reported two classes of orally bioavailable <i>C</i>-glycosidic inhibitors of the <i>Pseudomonas aeruginosa</i> lectin LecB with antibiofilm activity. They proved efficient in target binding, were metabolically stable, nontoxic, selective, and potent in inhibiting formation of bacterial biofilm. Here, we designed and synthesized six new carboxamides and 24 new sulfonamides for a detailed structure–activity relationship for two clinically representative LecB variants. Sulfonamides generally showed higher inhibition compared to carboxamides, which was rationalized based on crystal structure analyses. Substitutions at the thiophenesulfonamide increased binding through extensive contacts with a lipophilic protein patch. These metabolically stable compounds showed a further increase in potency toward the target and in biofilm inhibition assays. In general, we established the structure–activity relationship for these promising antibiofilm agents and showed that modification of the sulfonamide residue bears future optimization potential.

chemistry, medicinal